Peter Mcnamara Biography and Net Worth

Peter brings nearly 20 years of drug discovery experience in Pharma and Biotech to Tectonic. Most recently he was Head of Biotherapeutics and Biotechnology at the Genomics Institute of the Novartis Research Foundation (GNF), where he was responsible for GNF’s platform technologies in biotherapeutics discovery and optimization, structural biology, functional genomics, HTS, automation and engineering. Prior to this he was Head of Pharmacology and General Medical Biology and responsible for the scientific strategies and drug discovery activities pertaining to GNF’s programs across a broad range of disease areas with special emphasis on regenerative medicine and tissue repair. Peter led teams and functions that resulted in bringing over 10 molecules into clinical trials including FXR agonists LJN452 and LMB763 and contributing to three FDA approved drugs including Zykadia and Braftovi. Peter earned his PhD in Biochemistry from the National University of Ireland at Galway and was a post-doctoral Fellow at the University of Pennsylvania where he became a member of the Faculty at the Institute for Translational Medicine and Therapeutics in the School of Medicine.